The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.
Understanding the rate of erectile dysfunction (ED) and testosterone deficiency is crucial in developing screening and ...
For patients undergoing breast reconstruction after mastectomy, age impacts surgical outcomes, with older age negatively ...
Exposure to extreme heat stress is associated with increased risks for emergency department visits and unplanned hospital ...
Vaccination is one of the most effective ways to protect children against influenza and its complications, including severe ...
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...
Separate studies investigated the potential role of multiparametric MRI in refining prostate cancer active surveillance ...
The health sector's share of the economy was 17.6 percent in 2023, which was similar to 17.4 percent in 2022, but lower than the share in 2020 and 2021 during the height of the pandemic.
Compared with women with normotensive pregnancies, women with gestational hypertension, preeclampsia, and eclampsia all had ...
Donor-derived cell free DNA shows promise for identifying subclinical antibody-mediated rejection in kidney transplant ...
Researchers conducted a systematic literature review to examine the prevalence of and risk factors for multidrug resistant infections in patients with urinary tract infections.
There is an inverse relationship between an increase in MVPA and the fraction of physical activity energy expenditure derived ...